Literature DB >> 20096433

The utility of pre-operative peritoneal lavage examination in serosa-invading gastric cancer patients.

Tomoki Makino1, Yoshiyuki Fujiwara, Shuji Takiguchi, Hiroshi Miyata, Makoto Yamasaki, Kiyokazu Nakajima, Toshirou Nishida, Masaki Mori, Yuichiro Doki.   

Abstract

BACKGROUND: Peritoneal dissemination is frequently found during laparotomy in patients with serosa-invading gastric cancer. Detection of exfoliated cancer cells in abdominal lavage cytology is indicative of stage IV because of its strong association with peritoneal dissemination. Herein we have described peritoneal lavage cytology using a bedside procedure under local anesthesia.
METHODS: A prospective study of 113 patients with serosa-invading gastric cancer but without peritoneal metastases was performed. A drainage tube was inserted into the abdominal cavity for peritoneal lavage. Patients with negative cytology (CY0) were scheduled for curative gastrectomy.
RESULTS: The bedside procedure was performed safely without any complications. Lavage cytology identified CY1 in 35 (31.0%) patients and CY0 in 78 (69.0%) patients. Patients with CY0 underwent laparotomy and peritoneal lavage cytology, and 9 were found to have peritoneal disease (3 with operative CY1, 4 with peritoneal dissemination, and 2 with both operative CY1 and peritoneal dissemination). Two other patients had small, distant metastases. Finally, curative gastrectomy was achieved in 67 (59.3%) patients, but not in 46 (40.7%) patients. Thus, our bedside, pre-operative peritoneal lavage detected 76.1% (35/46) of noncurative disease before operative with a false-negative rate for detecting peritoneal disease of 20.5% (9/44). Patients with pre-operative CY1 had a poorer prognosis than pre-operative CY0 (2-year cause-specific survival 26.6% vs 82.6%).
CONCLUSION: Pre-operative bedside peritoneal lavage under local anesthesia followed by cytology is a simple and safe method for the pre-operative diagnosis of peritoneal dissemination and may help to reduce unexpected, noncurative surgery. Copyright 2010 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20096433     DOI: 10.1016/j.surg.2009.11.025

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  8 in total

1.  Lack of prognostic role of pre- and postoperative peritoneal cytology and cytokeratin PCR-expression on local recurrence after curative anterior resection for mid-low rectal cancer.

Authors:  Donato F Altomare; Michele Tedeschi; Maria-Teresa Rotelli; Domenica Bocale; Domenico Piscitelli; Marcella Rinaldi
Journal:  Updates Surg       Date:  2011-04-20

Review 2.  Molecular diagnosis and therapy for occult peritoneal metastasis in gastric cancer patients.

Authors:  Shunsuke Kagawa; Kunitoshi Shigeyasu; Michihiro Ishida; Megumi Watanabe; Hiroshi Tazawa; Takeshi Nagasaka; Yasuhiro Shirakawa; Toshiyoshi Fujiwara
Journal:  World J Gastroenterol       Date:  2014-12-21       Impact factor: 5.742

Review 3.  Detection value of free cancer cells in peritoneal washing in gastric cancer: a systematic review and meta-analysis.

Authors:  Francisco Tustumi; Wanderley Marques Bernardo; Andre Roncon Dias; Marcus Fernando Kodama Pertille Ramos; Ivan Cecconello; Bruno Zilberstein; Ulysses Ribeiro-Júnior
Journal:  Clinics (Sao Paulo)       Date:  2016-12-01       Impact factor: 2.365

Review 4.  Prognostic significance of peritoneal lavage cytology in staging gastric cancer: systematic review and meta-analysis.

Authors:  Sara Jamel; Sheraz R Markar; George Malietzis; Amish Acharya; Thanos Athanasiou; George B Hanna
Journal:  Gastric Cancer       Date:  2017-08-04       Impact factor: 7.370

5.  A decision analysis comparing three strategies for peritoneal lavage cytology testing in staging of gastric cancer in China.

Authors:  Qifei He; Jinyi Zhu; Anqiang Wang; Ke Ji; Xin Ji; Ji Zhang; Xiaojiang Wu; Xia Li; Zhaode Bu; Jiafu Ji
Journal:  Cancer Med       Date:  2020-10-13       Impact factor: 4.452

6.  NY-ESO-1 antibody as a novel tumour marker of gastric cancer.

Authors:  S Fujiwara; H Wada; J Kawada; R Kawabata; T Takahashi; J Fujita; T Hirao; K Shibata; Y Makari; S Iijima; H Nishikawa; A A Jungbluth; Y Nakamura; Y Kurokawa; M Yamasaki; H Miyata; K Nakajima; S Takiguchi; E Nakayama; M Mori; Y Doki
Journal:  Br J Cancer       Date:  2013-02-12       Impact factor: 7.640

7.  Test execution variation in peritoneal lavage cytology could be related to poor diagnostic accuracy and stage migration in patients with gastric cancer.

Authors:  Young-Jun Ki; Sun-Hee Ji; Jae Seok Min; Sung-Ho Jin; Sunhoo Park; Hang-Jong Yu; Ho-Yoon Bang; Jong-Inn Lee
Journal:  J Gastric Cancer       Date:  2013-12-31       Impact factor: 3.720

Review 8.  Free intraperitoneal tumor cells and outcome in gastric cancer patients: a systematic review and meta-analysis.

Authors:  Mathieu Pecqueux; Johannes Fritzmann; Mariam Adamu; Kristian Thorlund; Christoph Kahlert; Christoph Reißfelder; Jürgen Weitz; Nuh N Rahbari
Journal:  Oncotarget       Date:  2015-11-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.